A First-in-Human, Multicenter, Phase 1, Open-Label Study of XTX301 in Patients with Advanced Solid Tumors

Protocol No

XILIO-XTX301-01-02-001

Staff Member

William Bradley

Phase

I

Summary

This project is being done to determine if XTX301 is safe and well-tolerated in participants with advanced solid tumors.

Objective

A First-in-Human, Open-Label Study of XTX301 in Patients with Advanced Solid Tumors

Study Sites

Froedtert Hospital

Status

OPEN TO ACCRUAL

Categories

Cancer, Gynecologic Cancers, Thoracic Cancers, Colorectal, Early Phase/Multiple Disease Site Cancers, Kidney, Other Skin, Pancreas/Liver, Skin Cancers, Head and Neck Cancers, Gastrointestinal Cancers, Other Urologic, Prostate and Urologic Cancers, Sarcoma, Breast Cancers

ClinicalTrials.gov

https://www.clinicaltrials.gov/study/NCT05684965